SCHEMBL3677671

SCHEMBL3677671

CCCOC(CCl)OCCC

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16888431 0.92 THRB (0.35)
SCHEMBL9178697 0.83 ADRB2 (0.38) CA1CA2
SCHEMBL11567241 0.78 TSHR (0.30)
SCHEMBL31216413 0.78 ALDH1A1 (0.39)
SCHEMBL31697651 0.75 ALDH1A1 (0.33)
SCHEMBL4425572 0.75 CA1 (0.33) CA1CA2
Monochloroacetal SCHEMBL483679 0.75
SCHEMBL3032689 0.75 CA1 (0.33) CA1CA2
SCHEMBL11381692 0.75 CA1 (0.33) CA1CA2
SCHEMBL31490933 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4632111-A2 PROCESS FOR THE PREPARATION OF ACETALS OF ALPHA-CHLORO- OR ALPHA-BROMO-ALDEHYDES ESy-Labs-GmbH (DE) 2025-10-15 EP disclosed
EP-4632110-A1 PROCESS FOR THE HALOGENATION OF ORGANIC COMPOUNDS ESy-Labs-GmbH (DE) 2025-10-15 EP disclosed
US-7728152-B2 Process for producing 2-benzoyloxyacetaldehyde derivative DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2010-06-01 US disclosed
US-7692033-B2 Process for producing 2-benzoyloxyacetaldehyde derivative DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2010-04-06 US disclosed
US-20090192321-A1 PROCESS FOR PRODUCING 2-BENZOYLOXYACETALDEHYDE DERIVATIVE NISHIKAWA KAZUYOSHI 2009-07-30 US disclosed
US-20050234246-A1 Process for producing 2-benzoyloxyacetaldehyde derivative DAICEL CHEMICAL INDUSTRIES, LTD. 2005-10-20 US disclosed
US-5455361-A Process for preparing ketene acetals WACKER-CHEMIE GMBH (DE) 1995-10-03 US disclosed
EP-0589359-B1 Process for the production of ketene acetals WACKER CHEMIE GMBH (DE) 1995-06-28 EP disclosed
EP-0589359-A1 Process for the production of ketene acetals Wacker-Chemie GmbH (DE) 1994-03-30 EP disclosed
EP-0404694-A2 4-hydroxy-8-methoxy-2-methyl-6, 7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline, and process for preparing the same MITSUBISHI KASEI CORPORATION (JP) 1990-12-27 EP disclosed
EP-0387156-A2 A process for preparing cotarnine MITSUBISHI KASEI CORPORATION (JP) 1990-09-12 EP disclosed
EP-0247234-B1 PROCESS FOR THE MANUFACTURE OF ACETALS OF CHLORO- OR BROMOACETALDEHYDE National Starch and Chemical Corporation (US) 1990-01-17 EP disclosed
US-4769480-A Benzylamine derivative MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1988-09-06 US disclosed
EP-0247234-A1 Process for the manufacture of acetals of chloro- or bromoacetaldehyde National Starch and Chemical Corporation (US) 1987-12-02 EP disclosed
EP-0214051-A2 Benzylamine derivative MITSUBISHI KASEI CORPORATION (JP) 1987-03-11 EP disclosed
US-4642390-A Process for the manufacture of acetals of chloroacetaldehyde NATIONAL STARCH AND CHEMICAL CORPORATION (US) 1987-02-10 US disclosed
US-4163112-A INSECTICIDES VELSICOL CHEMICAL CORPORATION (US) 1979-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234246-A1 Process for producing 2-benzoyloxyacetaldehyde derivative ALDH1A1, ALDH2, CBR1 CA1 708/4885CA2 190/4885MAPK1 1902/4885
US-20090192321-A1 PROCESS FOR PRODUCING 2-BENZOYLOXYACETALDEHYDE DERIVATIVE ALDH1A1, ALDH2, CBR1 CA1 708/4885CA2 190/4885MAPK1 1902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.